MedPath
NMPA Approval

Olmesartan Medoxomil Tablets

国药准字H20253313

January 24, 2025

Drug Information

奥美沙坦酯片

片剂

20mg

化学药品

January 24, 2025

Company Information

Applicant Company

浙江省临海市汛桥

Manufacturing Company

浙江省临海市汛桥

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯片 - NMPA 批准文号 | MedPath